#8723. Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of na?ve HIV-infected patients starting antiretroviral therapy

November 2026publication date
Proposal available till 30-05-2025
4 total number of authors per manuscript3510 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Pharmacology (medical);
Infectious Diseases;
Microbiology (medical);
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
1050 $940 $820 $700 $
Contract №8723.1 Contract №8723.2 Contract №8723.3 Contract №8723.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
This study aimed to compare the durability of treatment with two different antiretroviral regimens prescribed to HIV-infected patients.
Keywords:
Dolutegravir; Elvitegravir; Raltegravir; Rilpivirine; Single-tablet regimen

Contacts :
0